Literature DB >> 17349969

Effect of potassium perfluorooctanesulfonate, perfluorooctanoate and octanesulfonate on the phase transition of dipalmitoylphosphatidylcholine (DPPC) bilayers.

W Xie1, I Kania-Korwel, P M Bummer, H-J Lehmler.   

Abstract

Perfluorooctanesulfonic acid (PFOS) is a persistent environmental pollutant that may cause adverse effects by inhibiting pulmonary surfactant. To gain further insights in this potential mechanism of toxicity, we investigated the interaction of PFOS potassium salt with dipalmitoylphosphatidylcholine (DPPC) - the major component of pulmonary surfactant - using steady-state fluorescence anisotropy spectroscopy and DSC (differential scanning calorimetry). In addition, we investigated the interactions of two structurally related compounds, perfluorooctanoic acid (PFOA) and octanesulfonic acid (OS) potassium salt, with DPPC. In the fluorescence experiments a linear depression of the main phase transition temperature of DPPC (T(m)) and an increased peak width was observed with increasing concentration of all three compounds, both using 1,6-diphenyl-1,3,5-hexatriene (DPH) and 1-(4-trimethylammoniumphenyl)-6-phenyl-1,3,5-hexatriene p-toluenesulfonate (TMA-DPH) as fluorescent probes. PFOS caused an effect on T(m) and peak width at much lower concentrations because of its increased tendency to partition onto DPPC bilayers, i.e., the partition coefficients decrease in the K(PFOS)>K(PFOA)>>K(OS). Similar to the fluorescence anisotropy measurements, all three compounds caused a linear depression in the onset of the main phase transition temperature and a significant peak broadening in the DSC experiments, with PFOS having the most pronounced effect of the peak width. The effect of PFOS and other fluorinated surfactants on DPPC in both mono- and bilayers may be one mechanism by which these compounds cause adverse biological effects.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17349969      PMCID: PMC1993895          DOI: 10.1016/j.bbamem.2007.02.003

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  33 in total

1.  Pharmacokinetic modeling of saturable, renal resorption of perfluoroalkylacids in monkeys--probing the determinants of long plasma half-lives.

Authors:  Melvin E Andersen; Harvey J Clewell; Yu-Mei Tan; John L Butenhoff; Geary W Olsen
Journal:  Toxicology       Date:  2006-08-12       Impact factor: 4.221

2.  Effects of perfluorooctanoic acid exposure during pregnancy in the mouse.

Authors:  Christopher Lau; Julie R Thibodeaux; Roger G Hanson; Michael G Narotsky; John M Rogers; Andrew B Lindstrom; Mark J Strynar
Journal:  Toxicol Sci       Date:  2006-01-16       Impact factor: 4.849

3.  Mixing of perfluorooctanesulfonic acid (PFOS) potassium salt with dipalmitoyl phosphatidylcholine (DPPC).

Authors:  H-J Lehmler; W Xie; G D Bothun; P M Bummer; B L Knutson
Journal:  Colloids Surf B Biointerfaces       Date:  2006-05-25       Impact factor: 5.268

4.  Interaction of surfactants with vesicle membrane of dipalmitoylphosphatidylcholine: fluorescence depolarization study.

Authors:  T Inoue; Y Muraoka; K Fukushima; R Shimozawa
Journal:  Chem Phys Lipids       Date:  1988-02       Impact factor: 3.329

5.  Effects of prenatal perfluorooctane sulfonate (PFOS) exposure on lung maturation in the perinatal rat.

Authors:  R C Grasty; J A Bjork; K B Wallace; D C Wolf; C S Lau; J M Rogers
Journal:  Birth Defects Res B Dev Reprod Toxicol       Date:  2005-10

6.  Neonatal mortality from in utero exposure to perfluorooctanesulfonate (PFOS) in Sprague-Dawley rats: dose-response, and biochemical and pharamacokinetic parameters.

Authors:  Deanna J Luebker; Raymond G York; Kristen J Hansen; John A Moore; John L Butenhoff
Journal:  Toxicology       Date:  2005-08-29       Impact factor: 4.221

7.  Alterations in cell membrane properties caused by perfluorinated compounds.

Authors:  Wen yue Hu; Paul D Jones; Wim DeCoen; Louis King; Pamela Fraker; John Newsted; John P Giesy
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2003-05       Impact factor: 3.228

8.  Perfluorooctane sulfonic acid is a potent inducer of peroxisomal fatty acid beta-oxidation and other activities known to be affected by peroxisome proliferators in mouse liver.

Authors:  A K Sohlenius; A M Eriksson; C Högström; M Kimland; J W DePierre
Journal:  Pharmacol Toxicol       Date:  1993-02

9.  Inhibition of gap junctional intercellular communication by perfluorinated compounds in rat liver and dolphin kidney epithelial cell lines in vitro and Sprague-Dawley rats in vivo.

Authors:  Wenyue Hu; Paul D Jones; Brad L Upham; James E Trosko; Christopher Lau; John P Giesy
Journal:  Toxicol Sci       Date:  2002-08       Impact factor: 4.849

10.  Sub-chronic dietary toxicity of potassium perfluorooctanesulfonate in rats.

Authors:  Andrew M Seacat; Peter J Thomford; Kris J Hansen; Lisa A Clemen; Sandra R Eldridge; Cliff R Elcombe; John L Butenhoff
Journal:  Toxicology       Date:  2003-02-01       Impact factor: 4.221

View more
  8 in total

1.  Partitioning of homologous nicotinic acid ester prodrugs (nicotinates) into dipalmitoylphosphatidylcholine (DPPC) membrane bilayers.

Authors:  Vivian Ojogun; Sandhya M Vyas; Hans-Joachim Lehmler; Barbara L Knutson
Journal:  Colloids Surf B Biointerfaces       Date:  2010-02-18       Impact factor: 5.268

2.  Biofunctionalization of electrospun PCL-based scaffolds with perlecan domain IV peptide to create a 3-D pharmacokinetic cancer model.

Authors:  Olga Hartman; Chu Zhang; Elizabeth L Adams; Mary C Farach-Carson; Nicholas J Petrelli; Bruce D Chase; John F Rabolt
Journal:  Biomaterials       Date:  2010-04-24       Impact factor: 12.479

3.  Gene Expression Profiling in Wild-Type and PPARα-Null Mice Exposed to Perfluorooctane Sulfonate Reveals PPARα-Independent Effects.

Authors:  Mitchell B Rosen; Judith R Schmid; J Christopher Corton; Robert D Zehr; Kaberi P Das; Barbara D Abbott; Christopher Lau
Journal:  PPAR Res       Date:  2010-09-27       Impact factor: 4.964

4.  Model and cell membrane partitioning of perfluorooctanesulfonate is independent of the lipid chain length.

Authors:  Wei Xie; Gabriele Ludewig; Kai Wang; Hans-Joachim Lehmler
Journal:  Colloids Surf B Biointerfaces       Date:  2009-10-27       Impact factor: 5.268

5.  Partitioning of perfluorooctanoate into phosphatidylcholine bilayers is chain length-independent.

Authors:  Wei Xie; Geoffrey D Bothun; Hans-Joachim Lehmler
Journal:  Chem Phys Lipids       Date:  2010-01-21       Impact factor: 3.329

6.  Disruption of phosphatidylcholine monolayers and bilayers by perfluorobutane sulfonate.

Authors:  E Davis Oldham; Wei Xie; Amir M Farnoud; Jennifer Fiegel; Hans-Joachim Lehmler
Journal:  J Phys Chem B       Date:  2012-08-13       Impact factor: 2.991

7.  Hydrophobic tail length, degree of fluorination and headgroup stereochemistry are determinants of the biocompatibility of (fluorinated) carbohydrate surfactants.

Authors:  Xueshu Li; Jaroslav Turánek; Pavlína Knötigová; Hana Kudlácková; Josef Masek; Sean Parkin; Stephen E Rankin; Barbara L Knutson; Hans-Joachim Lehmler
Journal:  Colloids Surf B Biointerfaces       Date:  2009-05-05       Impact factor: 5.268

8.  Subacute exposure to N-ethyl perfluorooctanesulfonamidoethanol results in the formation of perfluorooctanesulfonate and alters superoxide dismutase activity in female rats.

Authors:  Wei Xie; Qian Wu; Izabela Kania-Korwel; Job C Tharappel; Sanjay Telu; Mitchell C Coleman; Howard P Glauert; Kurunthachalam Kannan; S V S Mariappan; Douglas R Spitz; Jamie Weydert; Hans-Joachim Lehmler
Journal:  Arch Toxicol       Date:  2009-06-21       Impact factor: 5.153

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.